Evidence map›Paper›PMID 33503016›Full record

ArticleMedical science monitor : international medical journal of experimental and clinical research2021

Ginsenoside Rb1 Facilitates Browning by Repressing Wnt/β-Catenin Signaling in 3T3-L1 Adipocytes.

Qingxin Fan, Pengjiao Xi, Derun Tian, Lianqun Jia, Yuan Cao, Kaixuan Zhan, Tianwei Sun, Yinlong Zhang, Qiming Wang

Open access · hybridAbstract read
In one paragraph

Article in Medical science monitor : international medical journal of experimental and clinical research, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed
1.2field-weighted citation impact, top 23% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed, 13 citations in OpenAlex.

  1. Article
  2. Coixol and Sinigrin fromPharmaceuticals (Basel, Switzerland) · 2025
    Article
  3. Article
  4. Review
  5. Lycopene andPharmaceuticals (Basel, Switzerland) · 2024
    Article
  6. Review
  7. Natural products for treatment of premature ovarian failure: a narrative review.Journal of traditional Chinese medicine = Chung i tsa chih ying wen pan · 2023
    Review
  8. Signaling pathways in obesity: mechanisms and therapeutic interventions.Signal transduction and targeted therapy · 2022
    Review
  9. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 4 institutions in 1 country.

Qingxin FanDepartment of Anatomy and Histology, School of Basic Medical Sciences, Tianjin Medical University, Tianjin, China (mainland).
Pengjiao XiSchool of Medical Laboratory, Tianjin Medical University, Tianjin, China (mainland).
Derun TianDepartment of Anatomy and Histology, School of Basic Medical Sciences, Tianjin Medical University, Tianjin, China (mainland).
Lianqun JiaKey Laboratory of Ministry of Education for TCM Viscera-State Theory and Applications, Liaoning University of Traditional Chinese Medicine, Shenyang, Liaoning, China (mainland).
Yuan CaoKey Laboratory of Ministry of Education for TCM Viscera-State Theory and Applications, Liaoning University of Traditional Chinese Medicine, Shenyang, Liaoning, China (mainland).
Kaixuan ZhanKey Laboratory of Ministry of Education for TCM Viscera-State Theory and Applications, Liaoning University of Traditional Chinese Medicine, Shenyang, Liaoning, China (mainland).
Tianwei SunDepartment of Spinal Surgery, Tianjin People's Hospital, Tianjin, China (mainland).
Yinlong ZhangDepartment of Orthopedic Trauma, Tianjin People's Hospital, Tianjin, China (mainland).
Qiming WangDepartment of Anatomy and Histology, School of Basic Medical Sciences, Tianjin Medical University, Tianjin, China (mainland).
Tianjin Medical University · CNLiaoning University of Traditional Chinese Medicine · CNTianjin Hospital · CNTianjin People's Hospital · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

BACKGROUND The discovery of browning in white adipose tissue has provided new ideas for treating obesity. Many studies have reported that ginsenoside Rb1 (G-Rb1) has activity against diabetes, inflammation, and obesity, but further investigation is needed on the effect and mechanism of G-Rb1 on browning. MATERIAL AND METHODS We treated 3T3-L1 adipocytes with 0-200 μM G-Rb1, and 0.5 μM Compound 3f and 30 μM SKL2001 were used to activate Wnt/b-catenin signaling. Adipocyte activity was evaluated by Cell Counting Kit-8. Oil Red O staining was used to detect the lipid droplets. Quantitative real-time polymerase chain reaction was used to measure the expression of Cd-137, Cited-1, Txb-1, Prdm-16, and Ucp-1 mRNA. Western blotting was used to measure the expression of Ucp-1, pGSK-3ß (Ser 9), GSK- 3ß, and ß-catenin proteins. The expression of Ucp-1 was also detected with immunofluorescence. RESULTS Adipocyte activity was not affected by 0-100 μM G-Rb1. However, G-Rb1 dose-dependently reduced the accumulation of lipid droplets; increased the expression of Cd-137, Cited-1, Txb-1, Prdm-16, and Ucp-1 mRNA; and increased the expression of Ucp-1, pGSK-3ß (Ser 9), GSK-3ß, and ß-catenin proteins. The accumulation of lipid droplets and the expression of Ucp-1 protein decreased as b-catenin increased. CONCLUSIONS G-Rb1 at various concentrations (0-100 μM) promoted the browning of adipocytes in a dose-dependent manner. Further, we confirmed that activation of Wnt/ß-catenin signaling could inhibit browning. Therefore, the browning promoted by G-Rb1 may be associated with the inhibition of Wnt/ß-catenin signaling.

Indexed as

3T3-L1 CellsAdipocytesAdipocytes, WhiteAdipogenesisAdipose Tissue, WhiteAnimalsbeta CateninCell DifferentiationGinsenosidesLipid MetabolismLipidsMiceObesityTranscription FactorsWnt Signaling Pathwaybeta Cateninginsenoside Rb1GinsenosidesLipidsTranscription Factors

Identifiers

PMID33503016
PMCPMC7849207
OpenAlexW3121775760

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.